Skip to main content
Mauna Kea Technologies logo

Mauna Kea Technologies — Investor Relations & Filings

Ticker · MKEA ISIN · FR0010609263 LEI · 5493007KMDG4MFIGJJ63 PA Manufacturing
Open in API
Filings indexed 774 across all filing types
Latest filing 2016-05-11 Regulatory Filings
Country FR France
Listing PA MKEA

About Mauna Kea Technologies

https://www.maunakeatech.com/en/

Mauna Kea Technologies is a medical device company that develops and markets the Cellvizio® platform, a real-time in vivo cellular imaging system. The platform utilizes Confocal Laser Endomicroscopy (CLE) technology, enabling physicians to visualize tissue at the cellular level during medical procedures. This "optical biopsy" is performed using flexible, miniature fiber-optic probes (Confocal Miniprobes™) that are compatible with standard endoscopes. The core function of Cellvizio® is to provide immediate microscopic visualization, which aids in accelerating diagnosis, informing treatment strategies, and improving the precision of therapeutic interventions. Key applications include gastroenterology (for conditions such as Barrett's esophagus and pancreatic cysts), interventional pulmonology (lung cancer diagnostics), urologic oncology, and neurosurgery. The technology supports enhanced surgical procedures, including real-time margin assessment, and is being integrated with robotic surgery and AI-assisted imaging systems.

Recent filings

Filing Released Lang Actions
Forte présence du Cellvizio au Congrès Mondial des Pathologies Bronchiques et de Pneumologie Interventionnelle
Regulatory Filings Classification · 100% confidence The document is a press release dated May 11, 2016, from Mauna Kea Technologies, reporting on the strong presence and presentation of its Cellvizio platform at the 2016 World Congress of Bronchology and Interventional Pulmonology (WCBIP). It details symposiums, presentations by various doctors, and quotes from the CEO regarding the technology's application in pulmonary diseases. The text concludes with boilerplate 'About' information and investor relations contacts, and explicitly states, 'Ceci est un communiqué d'informations réglementaires diffusé par PR Newswire' (This is a regulatory information release distributed by PR Newswire). This structure strongly indicates a general regulatory announcement or press release that doesn't fit the specific financial report categories (10-K, IR, ER, etc.). Since it is a regulatory announcement that doesn't fit a more specific category like DIV, DIRS, or MANG, the most appropriate fallback is Regulatory Filings (RNS).
2016-05-11 French
Mauna Kea Technologies annonce la présentation du Cellvizio par Cook Medical au Congrès annuel de l'American Urological Association
Regulatory Filings Classification · 100% confidence The document is a press release dated May 9, 2016, announcing that Mauna Kea Technologies' partner, Cook Medical, is presenting the Cellvizio platform at the American Urological Association (AUA) annual congress. It discusses a partnership, product presentation at a medical conference, and upcoming market launch activities. This type of announcement, detailing business developments, partnerships, and product promotion outside of mandatory financial reporting periods (like 10-K or ER), typically falls under general regulatory announcements or investor relations communications. Since it is not a specific financial report (10-K, IR, ER), a management discussion (MDA), or a director dealing report (DIRS), and it is a formal announcement, it best fits the 'Regulatory Filings' (RNS) category as a general corporate update, or potentially an Investor Presentation (IP) if it were the presentation itself, but here it is an announcement *about* a presentation at a third-party event. Given the options, RNS serves as the best general regulatory/corporate announcement fallback.
2016-05-09 French
Mauna Kea Technologies Announces Cook Medical's Introduction of the Cellvizio Platform at the American Urological Association Annual Meeting
Regulatory Filings Classification · 100% confidence The document is a press release announcing that Mauna Kea Technologies' partner, Cook Medical, introduced the Cellvizio platform at the American Urological Association (AUA) annual meeting. The text discusses an event (a medical conference/meeting) and the activities surrounding it, rather than being a formal regulatory filing like a 10-K, an earnings release, or a specific financial report. Since it is an announcement related to a specific industry event (AUA Annual Meeting), and it doesn't fit the definitions for AGM-R (which is for the company's own AGM materials), ER, CT, or standard financial reports, the most appropriate category is the general 'Regulatory Filings' (RNS) as a miscellaneous corporate announcement, although it is primarily a press release about a product launch/showcase at a major industry event. Given the options, RNS serves as the best fit for a general corporate news announcement that isn't a core financial filing or specific event report like a Call Transcript.
2016-05-09 English
Mauna Kea Technologies Reports First Quarter 2016 Sales and Provides Business Update
Earnings Release Classification · 99% confidence The document is titled "MAUNA KEA TECHNOLOGIES REPORTS FIRST QUARTER 2016 SALES AND PROVIDES BUSINESS UPDATE". It contains detailed financial tables showing revenue results for the first quarter ended March 31, 2016, comparing them to Q1 2015. It also includes a business update, management commentary, and an announcement for a conference call to discuss these results. This structure—reporting on a specific, shorter fiscal period (Q1) with detailed financials and business commentary—is characteristic of an Interim/Quarterly Report (IR). It is more comprehensive than a simple Earnings Release (ER) which usually only provides highlights, and it is not the full annual report (10-K). The document explicitly covers the first quarter results. Q1 2016
2016-04-27 English
Mauna Kea Technologies : chiffre d'affaires T1 2016 et bilan d'activité
Earnings Release Classification · 98% confidence The document is titled "Mauna Kea Technologies : chiffre d'affaires T1 2016 et bilan d'activité" (Revenue T1 2016 and Business Review). It explicitly details the revenue figures (Chiffre d'affaires) for the first quarter (T1) ending March 31, 2016, broken down by category, geography, and activity. This content structure—reporting financial performance for a period shorter than a year with detailed figures—is characteristic of an Interim/Quarterly Report. Although it contains management commentary, the core purpose is the financial reporting for the period. It is not a brief announcement of a report (RPA/RNS) as it contains the full data tables and detailed commentary, nor is it the full Annual Report (10-K). Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2016
2016-04-27 French
Mauna Kea Technologies : chiffre d'affaires T1 2016 et bilan d'activité
Earnings Release Classification · 98% confidence The document is titled "MAUNA KEA TECHNOLOGIES : CHIFFRE D'AFFAIRES T1 2016 ET BILAN D'ACTIVITÉ" (Revenue T1 2016 and Activity Report) and explicitly announces the revenue for the first quarter (T1 2016) ending March 31, 2016. It contains detailed financial tables comparing T1 2016 results to T1 2015 results, including revenue breakdowns by category and geography. This content structure—a focused announcement of period-specific financial results (revenue, key metrics) without the full depth of a 10-K or a comprehensive half-year report (IR)—is characteristic of an Earnings Release (ER). Although it includes some operational updates, the primary focus is the quarterly financial performance announcement. It is not a full transcript (CT) or a comprehensive interim report (IR), but the initial release of period results. Q1 2016
2016-04-27 French

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.